Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Rectal Neoplasms 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Carcinoma, Hepatocellular 1 Advanced Solid Tumor 1 Advanced Pancreatic Cancer 1

Interventions

Capecitabine 42 Oxaliplatin 39 Fluorouracil 29 Leucovorin 23 Radiotherapy 22 Cetuximab 15 Bevacizumab 15 Irinotecan 13 Nivolumab 12 Magnetic Resonance Spectroscopy 11 Specimen Handling 9 Drug Therapy 9 Surgical Procedures, Operative 8 Folfox protocol 8 pembrolizumab 7 Radiotherapy, Intensity-Modulated 7 Chemoradiotherapy 7 Biopsy 7 trifluridine tipiracil drug combination 6 Radiation 6 tislelizumab 5 sintilimab 5 regorafenib 5 dehydroftorafur 5 X-Rays 5 Surveys and Questionnaires 5 Sigmoidoscopy 5 Endoscopy 5 Consolidation Chemotherapy 5 spartalizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rectal Neoplasms × penpulimab × 1 year × Clear all

NCT05576480 2025-08-28

SPARC

Ruijin Hospital

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡